Second Affiliated Hospital Of Soochow University
Clinical trials sponsored by Second Affiliated Hospital Of Soochow University, explained in plain language.
-
New hope for hard-to-treat cancers: drug combo targets stubborn tumors
Disease control Not yet recruitingThis study tests a combination of two treatments (cetuximab β and PRaG) in 40 adults with advanced solid tumors that have a protein called EGFR and are no longer helped by standard therapies. The goal is to see if the combo can shrink tumors or slow their growth. Participants wil…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
Mushroom-Derived pill plus radiation shows promise for tough cancers
Disease control Not yet recruitingThis study tests whether a combination of PRaG-1 tablets (made from a natural fungus), targeted radiation, immune-boosting shots, and immunotherapy can help people with advanced solid tumors that have not responded to standard treatments. About 65 participants will receive all tr…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Diabetes drug may shield stroke survivors from brain fog
Disease control Not yet recruitingThis study tests whether a common diabetes medication (a DPP4 inhibitor) can improve thinking and memory after a mild stroke in people with type 2 diabetes. About 312 adults aged 40-75 will take either the drug or a placebo for 180 days. The goal is to see if the drug reduces the…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 18, 2026 12:04 UTC